Furthermore, our work reveals a role for the RBP4-STRA6 pathway in regulating HFD-induced expression of LGR5 independent of obesity and, subsequently, the increased kinetics of tumor progression. This evidence concerns the gene RBP4 and obesity due to melanocortin 4 receptor deficiency.